About The Medical Condition RWJ15927
Find the definition of the medical term RWJ15927. RWJ15927 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
RWJ15927
| RWJ15927 Medical Condition |
|---|
What's The Definition Of The Medical Condition RWJ15927?
A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Benzylamines ‐ Toluenes in which one hydrogen of the methyl group is substituted…
- Axonal Reaction ‐ Pathologic changes that occur in the axon and cell body of a…
- Hospitals, Rural ‐ Hospitals located in a…
- Anoxemia ‐ Clinical manifestation of respiratory distress consisting of…
- Inductions, SOS ‐ An error-prone mechanism or set of functions for repairing damaged…
- Heart-Lung Bypasses ‐ Diversion of the flow of blood from the entrance of the right…
- Textbooks, Programmed ‐ Instruction in which learners progress at their own rate using…
- Network, Social ‐ Support systems that provide assistance and encouragement to…
- Fetoplacental Circulations ‐ The circulation of blood, of both the mother and the fetus, through…
- Controls, Forms ‐ A management function in which standards and guidelines are developed…